All you need to know about Hepatitis C

Dr Suresh Singhvi

Chronic Hepatitis C is a serious disease that can result in long-term health problems. Approximately 60,000 people die every year from Hepatitis C related liver disease.

1. What is Hepatitis C?

Cipla to launch generic Hepatitis C drug 'Hepcvir' in India

 Drug major Cipla today announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India.

Zydus Cadila launches Gilead's Hepatitis C drug in India

Drug firm Zydus Cadila  launched generic version of Gilead Sciences' Hepatitis C drug Sofosbuvir in India under the brand name 'SoviHep'.

Mylan to distribute Gilead's Hepatitis C drugs in India

US-based leading generic drugmaker Mylan Monday said it will sell in India two chronic Hepatitis C drugs of Gilead Sciences.

How to stop common cold, HIV virus in their tracks found

Scientists have cracked the code used by a major group of viruses to spread infections such as the common cold, HIV, hepatitis C and polio in the human body, a finding that could lead to new drugs to combat the diseases.

New hepatitis drugs raise political pressure in Spain

The arrival in Europe of better but pricier hepatitis C drugs has raised pressure on Spanish leaders over health spending cuts which sufferers say deprive them of life-saving treatments.

People who use cocaine, amphetamines at double suicide risk

People who use cocaine and amphetamines face almost two-fold greater risk of suicidal behaviour between people who inject drugs.

GSK hepatitis C shot shows promise, bodes well for Ebola vaccines

A new hepatitis C vaccine from GlaxoSmithKline based on the same technology as an experimental Ebola shot being fast-tracked through human trials has shown promise in early clinical tests, prompting strong and broad immune responses.

New 'miracle' drug eliminates Hepatitis C virus in up to 98 pc patients

Scientists have revealed that a new, which will be soon available on the NHS, has been shown to eliminate the virus per cent of patients.

Hepatitis C may become rare by 2036: Study

The deadly hepatitis C could become a rare disease by the year 2036 owing to new effective drugs and widespread screening, says a study.

New combination of pills curing hepatitis C patients revealed

A new study has revealed a combination of pills that cures 9 of 10 hepatitis C patients and is well tolerated by patients.

Forget injection, pills to cure hardest-to-treat hepatitis C

On this World Hepatitis Day, there`s good news for patients, particularly from India, for those suffering from hepatitis C.

India has the second highest number of Hepatitis B infected

India has over 40 million Hepatitis B infected patients, second only to China, and most people with chronic Hepatitis B or C are unaware of their infection, putting them at serious risk of developing cirrhosis or liver cancer which are life threatening.

Lack of blood screening causing Hepatitis C

Vardhan Singh, a 65-year-old patient of acute anaemia, met with an accident 25 years ago. The grievous injuries he suffered and the loss of blood compelled doctors to transfuse extra blood to his body.

New drug cures Hepatitis C in HIV patients

In a ray of hope for patients infected with both HIV and Hepatitis C, researchers have found that a combination drug therapy cures chronic Hepatitis C in majority of such patients.

Simple blood tests can save hepatitis patients

Blood tests can save more than 80 percent hepatitis C patients and over 60 percent hepatitis B patients when combined with proper prevention and treatment, say experts.

Need to address Hepatitis C, drug use: Experts

There was an urgent need to address issues like Hepatitis-C and adolescent drug use to prevent spread of HIV/AIDS, experts said Tuesday.

New combination of drug therapy could help treat Hepatitis C

Scientists have a new combination drug therapy that can effectively treat Hepatitis C.

Merck`s hepatitis C drugs show 98% cure rate in trial

Offering new hopes to millions of people infected with Hepatitis C, a two-drug combination by Merck & Co to treat the infectious liver disease has showed a cure rate of 98% in a mid-stage trial.

Researchers claim breakthrough in HIV,Hepatitis C with DNA vaccine

In a significant breakthrough by Australian scientists, a new type of DNA vaccine can help in tackling HIV and Hepatitis C.